Ionis Pharmaceuticals: Q3 Triggers The Latest Selloff On Tryngolza Disappointment

🇺🇸 Seeking Alpha (US) —

AI Summary

Ionis Pharmaceuticals’ shares reportedly faced a selloff after disappointing Q3 developments involving Tryngolza. The article title identifies the drug disappointment as a trigger, but the description provides no additional financial or clinical details.

Markets Health Ionis Pharmaceuticals Tryngolza Q3 share selloff drug disappointment pharmaceuticals biotech

Read original source →